INTESTINAL UPTAKE OF TC-99M MDP IN A PATIENT WITH VIPOMA SYNDROME

Authors
Citation
I. Bernay et M. Sahin, INTESTINAL UPTAKE OF TC-99M MDP IN A PATIENT WITH VIPOMA SYNDROME, Clinical nuclear medicine, 19(4), 1994, pp. 348-349
Citations number
11
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
ISSN journal
03639762
Volume
19
Issue
4
Year of publication
1994
Pages
348 - 349
Database
ISI
SICI code
0363-9762(1994)19:4<348:IUOTMI>2.0.ZU;2-B
Abstract
Vipoma syndrome, or the diarrheogenic syndrome, is often caused by a p ancreatic islet cell tumor or a retroperitoneal neural tumor and is ma inly characterized by watery diarrhea, hypokalemia, and achlorhydria. Vasoactive intestinal polypeptide (VIP) Is generally the mediator in m ost cases. Intestinal uptake of Tc-99m MDP in a 32-year-old man with V ipoma syndrome is reported. He had normal calcium and phosphate levels . Multiple intestinal biopsies revealed no metastatic calcifications, necrosis, or amyloidosis, but only diffuse intestinal edema and an 80- centimeter-long ischemic segment in the ileum. A synthetic somatostati n analog that was administered to the patient can also be the reason f or the intestinal concentration of Tc-99m MDP in this case. To our kno wledge, intestinal accumulation of a bone agent in the Vipoma syndrome has not been described.